1.
Chow RD, Guzman CD, Wang G, et al. AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma. Nat Neurosci. 2017;20(10):1329-1341. doi:10.1038/nn.4620.
1.
Crawford NG, Kelly DE, Hansen MEB, et al. Loci associated with skin pigmentation identified in African populations. Science. 2017;358(6365). doi:10.1126/science.aan8433.
1.
Liu H, Golji J, Brodeur LK, et al. Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss. Nat Med. 2019;25(1):95-102. doi:10.1038/s41591-018-0302-5.
1.
Oniangue-Ndza C, Kuntzen T, Kemper M, et al. Compensatory mutations restore the replication defects caused by cytotoxic T lymphocyte escape mutations in hepatitis C virus polymerase. J Virol. 2011;85(22):11883-90. doi:10.1128/JVI.00779-11.
1.
Jain IH, Zazzeron L, Goli R, et al. Hypoxia as a therapy for mitochondrial disease. Science. 2016;352(6281):54-61. doi:10.1126/science.aad9642.
1.
Liu DR, Magliery TJ, Schultz PG. Characterization of an ’orthogonal’ suppressor tRNA derived from E. coli tRNA2(Gln). Chem Biol. 1997;4(9):685-91.
1.
Cload ST, Liu DR, Froland WA, Schultz PG. Development of improved tRNAs for in vitro biosynthesis of proteins containing unnatural amino acids. Chem Biol. 1996;3(12):1033-8.